How effective is gemcitabin for lung cancer?

Gemcitabine for lung cancer is effective treatment in combination with cisplatin, but otherwise has no significant effect. Positive results for this combination are only qualified as one of several treatment options for not a small cellular lung cellular cancer, unlike the recommended treatment. Studies focused on gemcitabine on lung cancer combined with cisplatin and found positive results. Despite this, the drug used in itself is not effective as treatment and switching of cisplatin for other medicines such as carbopplatin, is also ineffective.

Cancer is caused by cell division outside the limitation normally stored by normal cells. Medicines such as gemcitabine are classified as antimetabolites that fancy as common substances that are part of the cells and prevent them from division when they are brought to the cell. Cancer is caused by unnecessary division of cells that are formed into the tumor. When gemcitabine is taken for lung cancer, it interferes with pyrimidine to avoid division and enlargeTumor size.

Research by gemcitabine on lung cancer suggests that it can be recommended for non-working lung cancer, but only when its use is combined using cisplatin. Immortal lung cancer, which is not as quickly spread as lung cancer with small cells, is the most common diversity of lung cancer. Three types of non -class lung cancer are adenocarcinomas, spinocellular carcinomas and large cell carcinomas. There are adenocarcinomas on the outside of the lungs, in the middle of the lungs there are carcinomas of spinocellular cells and large cell cancers can occur anywhere on the lungs. The fastest spreads large cell carcinomas and tumors grow much faster.

Studies have shown that the use of gemcitabine for lung cancer without other treatment is not effective. When the ridge has shown that the medicine has cisplatin, it has positive effects tailored to patients' survival.However, it has been shown that other combinations such as gemcitabin and carbopplatin or taxans are ineffective as primary treatment.

scientists speculated that certain molecules can be tested to indicate whether gemcitabine will be an effective treatment. If these predictors can be identified, doctors will have much easier work in determining the recommended treatment in patients who have lung cancer. Gemcitabin for lung cancer combined with cisplatin is only one of several options, but the genome -based approaches could facilitate adaptation of treatment and get a better result.